Hypoglycemia While Driving in Insulin-Treated Patients: Incidence and Risk Factors.
Journal
Journal of patient safety
ISSN: 1549-8425
Titre abrégé: J Patient Saf
Pays: United States
ID NLM: 101233393
Informations de publication
Date de publication:
01 12 2021
01 12 2021
Historique:
pubmed:
11
8
2020
medline:
19
2
2022
entrez:
11
8
2020
Statut:
ppublish
Résumé
This study aimed to investigate a potential daily-life concern for patients with diabetes hypoglycemia while driving by (1) estimating their incidence in insulin-treated drivers, (2) determining factors associated with their occurrence, and (3) analyzing patients' behavior regarding prevention of hypoglycemia. We conducted an observational study from November 2013 to May 2018 in the endocrinology-diabetology-nutrition department of our university hospital. All patients treated for diabetes older than 18 years admitted in the department were eligible. A specific questionnaire assessing attitudes, knowledge, and consequences of hypoglycemia was provided. In this study, only insulin-treated patients who regularly drive were analyzed. On the 233 insulin-treated drivers included, 45 (19%) self-reported at least 1 hypoglycemia while driving in the preceding year. Two factors were significantly associated with their occurrence: type 1 diabetes (odds ratio [OR] = 3.19; 95% confidence interval [CI] = 1.55-6.57) and experiences of asymptomatic hypoglycemia (OR = 2.20; 95% CI = 1.05-4.63). Awareness of the treatment hypoglycemia risk because of information provided by a medical specialist was also but nonsignificantly associated with hypoglycemia while driving (OR = 2.61; 95% CI = 0.86-7.92). Forty-one patients (18%) combined those 3 variables, 20 (49%) of them self-reported hypoglycemia while driving. Thirty-four percent of the patients never carried carbohydrates for hypoglycemia correction. Seventy-six percent do not monitor blood glucose level before driving. Our questionnaire allowed us to highlight that 19% our cohort of insulin-treated drivers declared experiencing hypoglycemia while driving. Risk factors identified and prevention data collected should help us better target patient education.
Identifiants
pubmed: 32773647
pii: 01209203-202112000-00052
doi: 10.1097/PTS.0000000000000764
doi:
Substances chimiques
Blood Glucose
0
Hypoglycemic Agents
0
Insulin
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e1034-e1039Informations de copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors disclose no conflict of interest.
Références
Seaquist ER, Anderson J, Childs B, et al. Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society. Diabetes Care . 2013;36:1384–1395.
Graveling AJ, Frier BM. Impaired awareness of hypoglycaemia: a review. Diabetes Metab . 2010;36 suppl 3:S64–S74.
Warren RE, Frier BM. Hypoglycaemia and cognitive function. Diabetes Obes Metab . 2005;7:493–503.
McAulay V, Deary IJ, Sommerfield AJ, et al. Attentional functioning is impaired during acute hypoglycaemia in people with type 1 diabetes. Diabet Med . 2006;23:26–31.
Graveling AJ, Deary IJ, Frier BM. Acute hypoglycemia impairs executive cognitive function in adults with and without type 1 diabetes. Diabetes Care . 2013;36:3240–3246.
Cox DJ, Gonder-Frederick L, Clarke W. Driving decrements in type I diabetes during moderate hypoglycemia. Diabetes . 1993;42:239–243.
Cox DJ, Gonder-Frederick LA, Kovatchev BP, et al. Progressive hypoglycemia’s impact on driving simulation performance. Occurrence, awareness and correction. Diabetes Care . 2000;23:163–170.
Cox DJ, Gonder-Frederick LA, Kovatchev BP, et al. The metabolic demands of driving for drivers with type 1 diabetes mellitus. Diabetes Metab Res Rev . 2002;18:381–385.
Schmied LS, Zulewski H. Glucose variations during driving in people with type 1 diabetes using a continuous glucose monitoring system. Diabetes Care . 2019;42:1340–1343.
Graveling AJ, Frier BM. Driving and diabetes: problems, licensing restrictions and recommendations for safe driving. Clin Diabetes Endocrinol . 2015;1:8.
Houlden RL, Berard L, Lakoff JM, et alDiabetes Canada Clinical Practice Guidelines Expert Committee. Diabetes and driving. Can J Diabetes . 2018;42 suppl 1:S150–s153.
Lorber D, Anderson J, Arent SAmerican Diabetes Association. Diabetes and driving. Diabetes Care . 2014;37 suppl 1:S97–S103.
Bieber-Tregear M, Funmilayo D, Amana A, et al. FMCSA Evidence Report: 2010 Update Diabetes and Commercial Motor Vehicle Driver Safety. Federal Motor Carrier Safety Administration, U.S. Department of Transportation . USA: MANILA Consulting Group, Inc.; 2011.
Goldenbeld C, van Schagen I. Diseases and Disorders-Diabetes, European Road Safety Decision Support System, developed by the H2020 project SafetyCube. 2016. Available at: https://www.roadsafety-dss.eu/assets/data/pdf/synopses/Diseases_and_Disorders_Diabetes_08122016.pdf . Accessed January 08, 2020.
Almigbal TH, Alfaifi AA, Aleid MA, et al. Safe driving practices and factors associated with motor-vehicle collisions among people with insulin-treated diabetes mellitus: results from the Diabetes and Driving (DAD) study. J Safety Res . 2018;65:83–88.
Graveling A, Frier B. Driving and diabetes: are the changes in the European Union licensing regulations fit for purpose? Br J Diabet . 2018;18:25–31.
Graveling AJ, Warren RE, Frier BM. Hypoglycaemia and driving in people with insulin-treated diabetes: adherence to recommendations for avoidance. Diabet Med . 2004;21:1014–1019.
Bell D, Huddart A, Krebs J. Driving and insulin-treated diabetes: comparing practices in Scotland and New Zealand. Diabet Med . 2010;27:1093–1095.
Stevens AB, Roberts M, McKane R, et al. Motor vehicle driving among diabetics taking insulin and non-diabetics. BMJ . 1989;299:591–595.
Harsch IA, Stocker S, Radespiel-Troger M, et al. Traffic hypoglycaemias and accidents in patients with diabetes mellitus treated with different antidiabetic regimens. J Intern Med . 2002;252:352–360.
Cox DJ, Penberthy JK, Zrebiec J, et al. Diabetes and driving mishaps: frequency and correlations from a multinational survey. Diabetes Care . 2003;26:2329–2334.
Eadington DW, Frier BM. Type 1 diabetes and driving experience: an eight-year cohort study. Diabet Med . 1989;6:137–141.
Cox DJ, Ford D, Gonder-Frederick L, et al. Driving mishaps among individuals with type 1 diabetes: a prospective study. Diabetes Care . 2009;32:2177–2180.
Clarke B, Ward JD, Enoch BA. Hypoglycaemia in insulin-dependent diabetic drivers. Br Med J . 1980;281:586.
Donnelly LA, Morris AD, Frier BM, et al. Frequency and predictors of hypoglycaemia in type 1 and insulin-treated type 2 diabetes: a population-based study. Diabet Med . 2005;22:749–755.
Malkani S, Kotwal A. Frequency and predictors of self-reported hypoglycemia in insulin-treated diabetes. J Diabetes Res . 2017;2017:7425925.
Cariou B, Fontaine P, Eschwege E, et al. Frequency and predictors of confirmed hypoglycaemia in type 1 and insulin-treated type 2 diabetes mellitus patients in a real-life setting: results from the DIALOG study. Diabetes Metab . 2015;41:116–125.
Frier BM. Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications. Nat Rev Endocrinol . 2014;10:711–722.
McNeilly AD, McCrimmon RJ. Impaired hypoglycaemia awareness in type 1 diabetes: lessons from the lab. Diabetologia . 2018;61:743–750.
Watson W, Currie T, Lemon J, et al. Driving and insulin-treated diabetes: who knows the rules and recommendations? Pract Diabetes Int . 2007;24:201–206.
Flanagan DE, Watson J, Everett J, et al. Driving and insulin–consensus, conflict or confusion? Diabet Med . 2000;17:316–320.
Min T, Younis N. Driving and insulin-treated diabetes: are we aware of changes in the Third European Driving Licence Directive? Diabet Med . 2016;33:553–554.
Broz J, Donicova V, Brabec M, et al. Could continuous glucose monitoring facilitate identifying diabetes patients with a higher risk of hypoglycemia during driving? J Diabetes Sci Technol . 2013;7:1644–1645.